Phase-2 study of imatinib in metastasized medullary thyroid carcinoma.

Abstract

15500 Background: Medullary thyroid carcinoma (MTC) is a relatively rare tumor that metastasizes to regional lymph nodes, lung, liver and bone. When surgery is no longer a curative treatment option, no effective systemic therapy is currently available. In most cases a (somatic or germline) mutation in the RET (REarranged during Transfection) gene is… (More)

Topics

  • Presentations referencing similar topics